CME Group stock declines in pre-market trading as Terry Duffy shifts to executive chairman role in 2027.
CME Group (CME) shares dropped 4.01% to $251.12 in pre-market trading Wednesday following the announcement of a CEO transition. Terry Duffy, currently chairman and CEO, will become executive chairman on March 1, 2027.
The derivatives marketplace did not immediately name a successor. Duffy has led CME since 2016, overseeing expansion in futures and options trading. The transition timeline extends over two years, allowing for a structured leadership change.
No immediate market reaction details were provided beyond the pre-market price movement.